Monsanto and Novozymes are teaming up to transform research and commercialization of sustainable microbial products that will provide a new platform of solutions for growers around the world. They’ve announced a long-term strategic alliance — the BioAg Alliance — which will allow the companies to leverage employees, technologies and commercial assets in their agricultural biological portfolios. The alliance will bring Novozymes’ commercial BioAg operations and capabilities within microbial discovery, development and production together with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities. This will result in a comprehensive research, development and commercial collaboration to help farmers globally meet the challenge of producing more with less in a sustainable way.
Novozymes CEO Peder Holk Nielsen says this game-changing alliance has the potential to transform global agriculture. He says the combined capabilities of these two companies create an innovation powerhouse with a unique opportunity and approach to unleash the transformational opportunity in naturally derived microbial solutions in agriculture. Monsanto Chief Technology Officer Dr. Robb Fraley says this collaboration will take Monsanto’s biological work from a technology to a full-fledged platform that represents the next layer of opportunity for growers to drive yield and productivity while helping the preservation of the Earth’s finite natural resources.